Kinetic Capital Partners

Kinetic Capital Partners is a private equity and venture capital firm based in Vancouver, Canada, founded in 2002. The firm specializes in later-stage, pre-IPO, and buyout investments, primarily targeting sectors such as life sciences, healthcare, medical devices, software, and telecommunications. Kinetic Capital Partners focuses on growth-stage companies, especially those at the commercialization stage, and typically invests between $1 million and $25 million in equity capital. The firm aims for investments in businesses with enterprise values ranging from $35 million to $100 million and an EBITDA of at least $8 million, often seeking a majority stake to maintain a controlling ownership position. In addition to private equity investments, Kinetic Capital Partners occasionally engages in opportunistic public market investments.

Frank Barker

Founder and Partner

Dallas H Ross

Founder and Partner

22 past transactions

Moko Yogurt

Venture Round in 2023
Moko Yogurt is a brand that focuses on various floured yogurt drinks and provides sucrose-free products.

CXIP Labs

Seed Round in 2022
CXIP Labs is a developer of NFT infrastructure solutions for the web3 ecosystem.

BlockApps

Series B in 2022
BlockApps, Inc. is a blockchain technology company founded in 2015 and based in Brooklyn, New York. It specializes in the development of the BlockApps STRATO platform, which allows enterprises to build, deploy, and manage Ethereum-based blockchain applications. STRATO supports the creation of hybrid private, consortium, and public blockchains, providing a comprehensive solution for various industries, including software startups, IT firms, and Fortune 500 companies. In addition to its core platform, BlockApps has introduced the STRATO Mercata Blockchain Protocol and Marketplace, facilitating the digital ownership of assets like whiskey casks, precious metals, carbon offsets, and collectibles through a network of verified partners. With a focus on enhancing data visibility, automating processes, and reducing reliance on intermediaries, BlockApps aims to enable secure and efficient decentralized application management. The company has garnered approximately $50 million in investments and has established strategic partnerships to further its mission.

WorldCoin

Venture Round in 2021
World is a company that connects users through a privacy-focused network designed for secure digital asset management. It offers a digital currency platform that emphasizes both privacy and transparency using a permissionless blockchain. The World App enables users to securely store their World ID, manage digital assets, and access various Mini Apps, promoting global connectivity and trust. Additionally, World provides an iris-scanning device that enhances digital identity security by storing biometric information, which helps discourage spammers from creating multiple accounts. This combination of secure identity management and digital currency aims to facilitate a reliable and user-friendly digital environment.

Dtravel

Seed Round in 2021
Dtravel operates a decentralized platform designed for the home-sharing economy, enabling both short and long-term stays. The platform allows transactions using cryptocurrency as well as traditional payment methods, eliminating the need for intermediaries in vacation rentals. By leveraging blockchain technology, Dtravel aims to restore ownership, control, and decision-making to users, enhancing the relationship between hosts and guests. This approach not only fosters transparency within the home rental market but also reduces fees, allowing guests to have a more tailored travel experience while engaging with the community.

Jet Protocol

Seed Round in 2021
Jet Protocol Holdings operates a decentralized lending and borrowing platform that aims to reduce transaction costs while enhancing efficiency. The platform specializes in innovative loan products and cross-chain interest rate arbitrage, allowing users to streamline their borrowing and lending transactions. By simplifying these processes, Jet Protocol facilitates more accessible and effective financial interactions in the decentralized finance space.

Flare Network

Venture Round in 2021
Flare is a powerful new blockchain with the first consensus protocol for external data. Decentralized applications on Flare can therefore trustlessly acquire and use information from other blockchains and real world data sources, solving the oracle problem and opening the door to a new era of utility. > Fast, decentralized and fully-insured bridges can connect smart contract chains multilaterally, unifying rather than fragmenting liquidity. > Non-smart contract assets such as BTC, XRP and DOGE can be brought on to Flare, and put to work earning yield in DeFi. > Full cross-chain composability enables decentralized applications to use the value, liquidity and information of multiple blockchains via a single deployment on Flare. > Seamless decentralized integration with Web2 data powers trustless use of real world data sources in Web3 dapps.

SubDAO

Funding Round in 2021
SubDAO Network is a DAO management platform designed to facilitate the creation and management of decentralized autonomous organizations (DAOs). Built on the Polkadot infrastructure, SubDAO aims to simplify the process for any organization to establish and govern a DAO. The platform offers a suite of tools that include blockchain-based digital agreement signing, asset management, and DAO social networking, enabling cross-chain management and bridging the gap between Web 2.0 and Web 3.0. Additionally, it provides functionalities for funding pool management, voting, and customization, allowing DAO creators and participants to maintain flexibility and control over their governance processes.

Convergence Finance

Seed Round in 2021
Convergence Finance is a decentralized exchange platform focused on tokenized real-world assets. By utilizing smart contracts, the platform aims to enhance liquidity and facilitate the trading of both real-world and crypto-native assets. Its innovative automated market maker model is designed to provide greater transparency and inclusivity for investors, transforming the way assets are traded in the digital landscape. Through this approach, Convergence Finance seeks to bridge traditional finance with blockchain technology, making asset trading more accessible and efficient for a broader audience.

Terra

Venture Round in 2021
Terra is a price-stable cryptocurrency designed for mass adoption. It builds financial infrastructure for the next generation of decentralized applications. Terra is backed by Luna, a decentralized asset that derives its value from transaction fees collected on the Terra network. Much like the moon stabilizes the earth’s rotation, Luna is Terra's eternal guardian of stability.

CERE Network

Venture Round in 2021
CERE Network is a blockchain-based customer relationship management (CRM) ecosystem focused on data integration and collaboration. Founded in 2019 and headquartered in San Francisco, the company provides a platform that extracts customer data from various CRM and customer data systems. This platform facilitates an open micro-services environment for businesses and vendors to collaborate and integrate their data effectively. By capturing the entire customer journey on the blockchain, CERE Network ensures that crucial user information, including purchases and achievements, is securely stored in user wallets. Additionally, the ecosystem incorporates tokens that enable users to pay for services within the platform.

Orange Schade

Seed Round in 2020
Orange Schade is a service provider specializing in a range of automotive solutions, including car damage repair and replacement vehicle services. The company has established a comprehensive network of auto body repair shops, ensuring a wide variety of services for its customers. Additionally, Orange Schade offers the easy2fix service, which is recognized by Opel for its efficiency in handling damage repairs. This diverse portfolio allows Orange Schade to cater to various customer needs effectively, positioning the company as a reliable choice in the automotive repair sector.

Reef Finance

Seed Round in 2020
Reef Finance is a decentralized finance (DeFi) platform that operates on the Polkadot network, focusing on cross-chain functionality. Established in 2019 by CEO Denko Mancheski, the platform provides a liquidity aggregator and yield engine that facilitates trading with access to liquidity from both centralized exchanges (CEXes) and decentralized exchanges (DEXes). It offers services such as smart lending, borrowing, staking, and mining, all powered by an artificial intelligence-driven personalized yield engine. Reef Finance was notably the first project launched on Binance Launchpool, emphasizing its innovative approach within the DeFi landscape. The company is headquartered in Wilmington, Delaware.

Linear Finance

Seed Round in 2020
Linear Finance operates a decentralized delta-one asset protocol that allows users to create, manage, and trade synthetic assets across multiple blockchains with unlimited liquidity. The platform is designed to facilitate the trading of various assets, including commodities like bitcoin and crude oil, as well as market indices and e-sports. Leveraging a blend of technical expertise from the crypto sector and financial knowledge from traditional asset management, Linear Finance aims to provide a cost-effective and efficient trading experience. The company is based in New Territories, Hong Kong.

ThunderCore

Series A in 2019
ThunderCore operates a high-performance public blockchain compatible with the Ethereum Virtual Machine (EVM). It employs a proprietary consensus protocol called PaLa, which addresses scalability challenges and enables rapid transaction processing at over 4,000 TPS with confirmation times under one second. The network's native currency, TT, facilitates secure and low-cost transactions, with gas fees costing less than a fraction of a cent. ThunderCore serves an international user base across over 190 countries, supporting decentralized applications (dApps) with enhanced security and scalability.

Eximchain

Initial Coin Offering in 2018
Eximchain is a digital platform designed to streamline the global sourcing process for small and medium-sized businesses. It offers a comprehensive service that includes data-driven analysis, customized recommendations, and direct connections with suppliers. Utilizing blockchain technology, Eximchain facilitates secure and efficient transactions, allowing businesses to eliminate traditional supply chain barriers and integrate various actors into a transparent network. The platform features smart contracts to automate trade funding, helps establish creditworthiness data, and enables collaboration between importers and exporters in creating trade documents. Additionally, Eximchain builds a reputation system to assess supplier reliability based on transaction history and stores contracts and performance proof on the blockchain. The company is headquartered in the United States.

Bluzelle

Initial Coin Offering in 2018
Bluzelle is a developer of a blockchain database aimed at addressing data storage and management challenges for decentralized applications. The company's solutions provide multi-region coverage and widespread availability, enhancing network security and scalability while minimizing global impact. Bluzelle's offerings are designed to keep data fresh and secure, protecting it from hackers and ensuring resistance to censorship. Catering to a diverse clientele that includes small and medium-sized enterprises as well as large corporations, Bluzelle focuses on creating integrated blockchain applications, middleware, and data services tailored to meet the specific needs of its customers.

VisCardia

Series B in 2017
VisCardia, Inc. is a medical device company based in Beaverton, Oregon, established in 2015. The company focuses on developing and commercializing a proprietary implantable therapy aimed at patients with refractory heart failure. VisCardia's innovative approach involves a fully implantable electronic sensor and electrode system that provides chronic electrical stimulation to enhance thoracic pressure. This therapy utilizes the patient's own thoracic musculature to improve cardiac filling and output, alleviating symptoms associated with hemodynamic insufficiency. By addressing the challenges faced by patients with severe heart conditions, VisCardia aims to offer a novel solution in the field of cardiac health.

Protiva Biotherapeutics

Venture Round in 2007
Protiva Biotherapeutics, Inc. is a biotechnology company specializing in the development of nucleic acid-based pharmaceutical products aimed at combating a range of human diseases, including cancer, influenza, Ebola, inflammatory conditions, and chronic viral infections. The company’s product portfolio features Pro 1, a tumor cell growth inhibitor, and Pro-101, an siRNA product designed to impede the production of a protein associated with tumor growth. Additionally, Protiva develops Pro-B, which inhibits the expression of apolipoprotein B, as well as Pro-EBOV and Pro-MARV, targeting the replication of the Ebola and Marburg viruses. The company employs Stable Nucleic-Acid Lipid Particle technology for effective delivery of nucleic acid therapies, including short interfering RNA (siRNA). Protiva is also engaged in developing siRNA products for the treatment of hepatitis B and C. Founded in 2000, Protiva Biotherapeutics operates a research and development facility in Vancouver, Canada, and is based in Seattle, Washington. As of 2008, it functions as a subsidiary of Tekmira Pharmaceuticals Corp.

U-Systems

Venture Round in 2007
Usystems specializes in the design, development, and manufacture of advanced ultrasound systems and software aimed at enhancing breast cancer detection, particularly in women with dense breast tissue. The company's innovative products provide high-quality 3D ultrasound images that assist radiologists in identifying areas of concern within breast tissue. In addition to its focus on medical imaging, Usystems is dedicated to creating cutting-edge racking enclosures and cooling solutions that minimize noise, heat, and operational costs in data centers and office environments. Through a commitment to quality and innovation, Usystems employs state-of-the-art manufacturing processes to deliver effective solutions in both healthcare and data management sectors.

AgInfoLink

Series A in 2007
AgInfoLink Inc. designs and develops traceability solutions for the food industry. It offers data collection, secure data transmission, data warehousing, reporting, and analysis tools for linking information for individual animal management, regulatory compliance, and business performance. The company provides Pony Express, a data sharing solution to create and customize a data sharing network for supply chain; BeefLink, a personal computer-based data collection and management system to capture and store data automatically from RFID and barcode tags, scales, and other devices; AgInfoReports and AgInfoSheets reporting systems; and AgMobile, a handheld unit and wireless RFID reader that allows livestock producers to identify animals, record data, and reference historical data. AgInfoLink, Inc. also offers CattleCard, a data collection solution, for customers without computers, to collect group data and individual data using a barcode label sticker and RFID identifier; Tag Tracker, a rugged hand-held wireless RFID reader reads an RFID tag and communicates with a base station; and Animal Logger, a solution for collecting NAIS required and basic animal movement information, as well as WebReporting and Decision Pro tools, and processed verification programs. It serves state regulators, meat processors, retail/foodservice, and livestock producers. The company was founded in 1997 and is based in Longmont, Colorado.

Protiva Biotherapeutics

Series C in 2006
Protiva Biotherapeutics, Inc. is a biotechnology company specializing in the development of nucleic acid-based pharmaceutical products aimed at combating a range of human diseases, including cancer, influenza, Ebola, inflammatory conditions, and chronic viral infections. The company’s product portfolio features Pro 1, a tumor cell growth inhibitor, and Pro-101, an siRNA product designed to impede the production of a protein associated with tumor growth. Additionally, Protiva develops Pro-B, which inhibits the expression of apolipoprotein B, as well as Pro-EBOV and Pro-MARV, targeting the replication of the Ebola and Marburg viruses. The company employs Stable Nucleic-Acid Lipid Particle technology for effective delivery of nucleic acid therapies, including short interfering RNA (siRNA). Protiva is also engaged in developing siRNA products for the treatment of hepatitis B and C. Founded in 2000, Protiva Biotherapeutics operates a research and development facility in Vancouver, Canada, and is based in Seattle, Washington. As of 2008, it functions as a subsidiary of Tekmira Pharmaceuticals Corp.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.